[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357236-105":59,"doc-detail-357236-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-an-immune-related-diagnostic-signature-for-breast-cancer-bone-metastasis","Development and validation of an immune-related diagnostic signature for breast cancer bone metastasis","","Study investigates mechanisms linking immune-related genes with breast cancer (BC) bone metastasis and builds a clinically relevant diagnostic signature. Training data derive from TCGA-BC, combining differential expression analyses, weighted gene co-expression network analysis, univariate Cox regression, and LASSO to construct a risk model, then validate using GEO (GSE20685). Immune infiltration, ceRNA regulatory networks, and drug sensitivity are assessed, and qRT-PCR confirms expression patterns. Results identify six diagnostic genes and characterize immune differences between risk groups.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-an-immune-related-diagnostic-signature-for-breast-cancer-bone-metastasis/357236/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-an-immune-related-diagnostic-signature-for-breast-cancer-bone-metastasis/357236.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on breast cancer bone metastasis?","Question",{"text":112,"@type":113},"To explore mechanisms linking immune-related genes to breast cancer bone metastasis and develop a diagnostic signature that can distinguish bone-metastasis status.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate diagnostic genes selected and the risk model built?",{"text":117,"@type":113},"Differentially expressed genes and WGCNA module genes were integrated, then univariate Cox regression and LASSO were used to construct the diagnostic risk model.",{"name":119,"@type":110,"acceptedAnswer":120},"How was the diagnostic signature validated and what key confirmation method was used?",{"text":121,"@type":113},"Validation used the GEO dataset GSE20685, and clinical validation employed qRT-PCR, which confirmed expression directions for key genes such as ESRRA and OGFR.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357236,1790871351,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDevelopment and validation of an immune-related diagnostic signature for breast cancer bone metastasis  \nJing Tang1,2,4, Qiang Liu2,4, Zhengyong Tao2,4, Ningkui Niu3, Wenhua Zhan3􀀍, Jiandang Shi1􀀍 & Zongqiang Yang3􀀍  \nBone is one of the distant metastases in patients with Breast Cancer (BC) . However, the mechanism of BC bone metastasis is not fully understood. The aim of this study was to investigate the potential mechanisms linking bone metastasis-related genes and BC.The training set consisted of data from The Cancer Genome Atlas (TCGA)-BC dataset, which included 1,104 breast cancer samples (comprising 50 with bone metastasis and 1,052 without) and 114 adjacent normal samples. Differentially expressed genes (DEGs1) between breast cancer and normal tissues, as well as DEGs2 between breast cancer bone metastatic and non-bone metastatic tissues, were identified. Weighted gene co-expression network analysis (WGCNA) was then applied to screen breast cancer-related module genes. The intersection of these three sets was taken to obtain candidate genes. Diagnostic genes were identified via univariate Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) analysis to construct a risk model, which was subsequently validated using the Gene Expression Omnibus (GEO) dataset GSE20685 (327 samples, validation set) . Furthermore, immune infiltration analysis, mRNAmiRNA-lncRNA regulatory network construction, and drug sensitivity analysis were performed in the training set. Finally, quantitative reverse transcription polymerase chain reaction (qRT-PCR) was conducted on clinical samples for validation.There were 756 DEGs between BC and control samples. A sum of 6 BC-related modules were acquired by WGCNA. After screening, 997 bone metastasisassociated genes and 73 candidate genes were acquired. A total of 6 diagnostic genes, namely ABHD8, ESRRA, DHPS, ISOC2, MRPL34 andOGFR, were obtained to construct the risk model. Results of the immune microenvironment analysis revealed that the high-risk group exhibited lower levels of certain immune cells, such asT cells and CD8+ T cells. Based on the public database,ESRRA was regulated by various miRNAs, such as hsa-miR-185-3p, hsa-miR-2115-5p. Based on the results of molecular docking experiments, a sum of 67 drugs had significant differences in IC50 between two risk subgroups. Transcriptomic data from TCGA indicated that all six diagnostic genes were significantly upregulated in the BC group (p \u003C 0.05) . However, qRT-PCR validation showed that ESRRA andOGFR were significantly downregulated in the BC group (p \u003C 0.05), while the expression trends ofthe remaining four genes were consistent with the transcriptomic data.We explored the diagnostic genes (ABHD8, ESRRA, DHPS, ISOC2, MRPL34, and OGFR) of bone metastasis in BC, providing a reference for disease-related study.  \nKeywords Breast cancer, TCGA, GEO, Osseous metastasis, Diagnostic signature, Immune characteristics  \nAbbreviations  \nBC Breast cancer  \nccRCC Clear cell renal cell carcinoma MAGs Metastasis-associated genes TCGA The cancer genome atlas  \n1Department of Radiotherapy, General Hospital of Ningxia Medical University, Yinchuan, China. 2First Clinical Medical College of Ningxia Medical University, Yinchuan, China. 3Department of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, China. 4Jing Tang, Qiang Liu, Zhengyong Tao have contributed equally.  \n􀀍 [email: zhanwhgood@163.com](email: zhanwhgood@163.com); [shijiandang@nxmu.edu.cn](shijiandang@nxmu.edu.cn); yzq_[nyzy@126.com](nyzy@126.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nGEO Gene expression omnibus DEGs Differentially expressed genes GO Gene ontology  \nK-M Kaplan-meier analysis  \nROC Receiver operating characteristic GSVA Gene set variation analysis GDSC Drug sensitivity in cancer  \nGlobally, breast cancer represents a major health","cbCaipUsnGSphumc","https://ap.wps.com/l/cbCaipUsnGSphumc","pdf",11504676,"English","# Background\n## Breast cancer burden and unmet clinical needs\n# Methods\n## Differential expression and WGCNA module screening\n## Candidate gene selection and risk model construction\n## Validation datasets and experimental confirmation\n## Immune infiltration and regulatory network analyses\n# Results\n## Differentially expressed genes, modules, and candidate genes\n## Diagnostic signature genes and risk model performance\n## Immune microenvironment differences\n## miRNA regulation and drug sensitivity findings\n## qRT-PCR validation outcomes","[{\"question\":\"What is the main goal of the study on breast cancer bone metastasis?\",\"answer\":\"To explore mechanisms linking immune-related genes to breast cancer bone metastasis and develop a diagnostic signature that can distinguish bone-metastasis status.\"},{\"question\":\"How were candidate diagnostic genes selected and the risk model built?\",\"answer\":\"Differentially expressed genes and WGCNA module genes were integrated, then univariate Cox regression and LASSO were used to construct the diagnostic risk model.\"},{\"question\":\"How was the diagnostic signature validated and what key confirmation method was used?\",\"answer\":\"Validation used the GEO dataset GSE20685, and clinical validation employed qRT-PCR, which confirmed expression directions for key genes such as ESRRA and OGFR.\"}]","Development and validation of an immune-related diagnostic signature for breast cancer bone metastasis | PDF",1790129426,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f9df8bf3a058def63004fe8bb78d41d.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/582cc4ca34bf33f3cca9621ca6c70670.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39ce8372133b42eb30a6570f99adce59.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86119a637a02c14e63a0041ecf391861.webp",980,1287]